Kyverna Therapeutics
Developing cell therapies for autoimmune diseases
- B2B
About Kyverna Therapeutics
A clinical-stage biopharmaceutical company focused on developing cell therapies for autoimmune diseases, with a pipeline including CAR T-cell therapies
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Emeryville, California, United States
- Founded
- 2018
- Revenue
- $19.9M – $157MTamtam estimate
- Website
- kyvernatx.com
- linkedin.com/company/kyverna
Kyverna Therapeutics at a glance
Kyverna Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Emeryville, California, United States.
Kyverna Therapeutics was founded in 2018.
Kyverna Therapeutics has 51–250 employees.
Kyverna Therapeutics's revenue is $19.9M – $157M (Tamtam estimate).
Frequently asked questions about Kyverna Therapeutics
What is Kyverna Therapeutics's revenue?
Tamtam estimates Kyverna Therapeutics's annual revenue at $19.9M – $157M.
How many employees does Kyverna Therapeutics have?
Kyverna Therapeutics has 51–250 employees.
Where is Kyverna Therapeutics headquartered?
Kyverna Therapeutics is headquartered in Emeryville, California, United States.
Selling to companies like Kyverna Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies